NCT00114153 Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00113399 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Status TERMINATED Phase PHASE3
NCT00113347 Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) Status COMPLETED Phase PHASE1
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00103155 Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer Status UNKNOWN Phase PHASE1
NCT00102635 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC) Status TERMINATED Phase PHASE1
NCT00101582 Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00101335 Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia Status COMPLETED Phase PHASE2
NCT00100828 Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer Status TERMINATED Phase PHASE2
NCT00100789 S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00099021 Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia Status COMPLETED Phase PHASE2
NCT00098852 Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer Status UNKNOWN Phase PHASE2
NCT00096707 Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00096174 Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00095875 Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) Status COMPLETED Phase PHASE3
NCT00095836 Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy Status COMPLETED Phase PHASE2